Score an arrangement, not a company logo. Create a separate assessment for each material combination of product, facility, operating model, geography and patient cohort.
Use this assessment identity:
Contracting entity + dispensing/manufacturing facility + exact product/presentation + intended use + destination states + payment route + forecast volume + review date
Before requesting quotations, complete the following brief:
| Field | Required buyer input |
|---|---|
| Decision | Replacement, renewal, new-state launch, additional capacity or access redesign |
| Operating model | Clinic-stock purchasing, patient-specific dispensing, facilitated branded access, or a combination |
| Product scenario | Exact medicine, formulation, strength, presentation, pack size and clinician-approved use |
| Demand | Expected starts, continuing patients, prescribed dose mix and seasonal or launch peaks |
| Geography | Mandatory launch states, optional expansion states and delivery constraints |
| Money flows | Who pays for medicine, dispensing, shipping, software, support and replacements |
| Service requirements | Clinically approved delivery windows, support coverage and reporting requirements |
| Commercial limits | Maximum deposit, minimum commitment, patient affordability ceiling and termination exposure |
| Decision owners | Procurement lead, COO, medical director, counsel, finance and security reviewer |
Do not compare unlike products as if they were clinically interchangeable. Have clinical leadership define separate scenarios; procurement then evaluates the access arrangements within each scenario.
Manufacturer-linked programmes also need a complete workflow assessment. LillyDirect describes a patient-facing service fulfilled through third-party dispensing pharmacies; NovoCare describes prescriptions sent from the prescriber’s EHR and medicines purchased directly by patients. Neither description establishes a clinic wholesale-purchasing account. (lilly.com)
Explore the table row by row
A working view of the research
Decision
- Required buyer input
- Replacement, renewal, new-state launch, additional capacity or access redesign
Sources cited on this page
- lilly.com · Source 1 ↗https://www.lilly.com/lillydirect/faq?utm_source=openai